August 11, 2026

TRT in Saint Paul: A Physician’s Honest Assessment of Who Benefits and Who Does Not

By Kyle Kingsley, MD
Medical Director, Lite Medical PLLC

Estimated Reading Time: 8 minutes

Testosterone replacement therapy has never been more visible — or more misunderstood. Clinics advertise it broadly, wellness podcasts endorse it enthusiastically, and men across the Twin Cities are asking about it with increasing frequency. That visibility is, in some ways, a good thing. But it has also created a problem: the conversation has shifted away from careful clinical evaluation and toward a treatment-first mentality that does not serve every patient well.

Here is the honest truth. TRT is one of the most effective interventions available for men with confirmed hypogonadism. When it is prescribed appropriately, based on thorough lab work and a complete clinical picture, it can meaningfully restore energy, cognition, body composition, libido, and mood. The evidence for this is substantial and growing.

But TRT is not right for everyone. Men with testosterone levels in the normal range who are struggling with fatigue may be dealing with sleep apnea, thyroid dysfunction, insulin resistance, or vitamin D deficiency — conditions that TRT will not fix. Men who are hoping to improve fertility, men with certain cardiovascular histories, and men whose symptoms have other identifiable causes often need a different conversation entirely.

At Lite Medical PLLC, physician-led care means that conversation happens before any treatment decision is made. We see patients from across the Twin Cities, including Saint Paul, and the most valuable service we provide is not a prescription — it is an honest evaluation that points you toward the right answer, whether that includes TRT or not.

Key Takeaways

TRT provides significant clinical benefits for men with confirmed hypogonadism — but not for men with normal testosterone levels experiencing nonspecific symptoms.
A complete evaluation includes total testosterone, free testosterone, LH, FSH, SHBG, estradiol, CBC, and metabolic markers — not a single total T draw.
Symptoms like fatigue, low libido, and brain fog have many causes beyond low testosterone; ruling out alternatives is essential before initiating therapy.
The American Urological Association, Endocrine Society, and American College of Physicians all recommend confirming low testosterone on two separate morning draws before initiating TRT.
TRT is contraindicated in men actively trying to conceive; fertility-preserving alternatives such as clomiphene or HCG exist.
Ongoing monitoring of hematocrit, PSA, lipids, and testosterone levels is a non-negotiable component of responsible TRT management.
Physician-led evaluation protects patients from both undertreating real hypogonadism and overtreating conditions that require different interventions.

Table of Contents

What Is TRT — and What Is It Not?
How Testosterone Affects the Male Body
Who Benefits From TRT
Who Does Not Benefit From TRT
How We Evaluate Candidacy: The Diagnostic Process
What the Research Shows
Myths vs. Facts
Lite Medical’s Clinical Approach
Hormone Health in Saint Paul: What We See at Lite Medical
Frequently Asked Questions

What Is TRT — and What Is It Not?

Testosterone replacement therapy is a medical intervention designed to restore testosterone levels in men whose bodies do not produce sufficient testosterone on their own. It is not a performance-enhancing shortcut. It is not a lifestyle upgrade for men with normal hormone levels who want more energy. And it is not a treatment that every man asking about it will actually benefit from.

TRT comes in several delivery forms — intramuscular injections (typically testosterone cypionate or enanthate), subcutaneous injections, topical gels and creams, and pellets. Each has a different pharmacokinetic profile, and the right choice depends on the patient’s lifestyle, preferences, and clinical goals.

The goal of TRT is replacement — restoring testosterone to a physiologically healthy range — not supraphysiologic elevation. This distinction matters. The benefits documented in clinical literature apply to men moving from deficient levels into normal range, not from normal into supra-normal territory. That distinction is one of the most important things a physician can help a patient understand before treatment begins.

Hypogonadism — the clinical term for testosterone deficiency — affects an estimated 2–4% of men under 40 and rises significantly with age. It can be primary (the testes themselves produce insufficient testosterone) or secondary (the hypothalamic-pituitary axis fails to send the appropriate signals). The distinction matters because it affects both diagnosis and, in some cases, treatment selection.

How Testosterone Affects the Male Body

Testosterone is not simply a sex hormone. It is an anabolic signaling molecule that influences nearly every major physiological system in the male body.

In muscle and bone, testosterone stimulates protein synthesis and promotes bone mineral density. Deficiency accelerates sarcopenia (muscle loss) and increases fracture risk — effects that compound steadily after the age of 40 if left unaddressed.

In the brain, testosterone interacts with androgen receptors in regions associated with motivation, reward, spatial cognition, and mood regulation. This is why men with low testosterone frequently report depression, brain fog, reduced drive, and difficulty concentrating — symptoms that are often attributed to stress or aging before a hormonal cause is considered.

In metabolic function, testosterone plays a meaningful role in insulin sensitivity and body composition. Men with hypogonadism show higher rates of visceral fat accumulation and insulin resistance, and studies published in the Journal of Clinical Endocrinology and Metabolism have found that restoring testosterone improves these markers in appropriately selected patients.

In cardiovascular function, testosterone’s role is more nuanced. Historical concerns about cardiovascular risk have been substantially revised. The TRAVERSE trial — a large randomized controlled trial published in 2023 in the New England Journal of Medicine — found no increased risk of major adverse cardiovascular events in men with hypogonadism treated with testosterone gel versus placebo, though it also noted a modestly higher rate of atrial fibrillation and pulmonary embolism that warrants individualized assessment.

Libido, erectile function, semen parameters, and fertility are also testosterone-sensitive. TRT improves libido in most hypogonadal men but generally suppresses sperm production — an important consideration discussed in detail below.

Who Benefits From TRT

The men who benefit most from TRT share a specific clinical profile. Benefit requires all of the following:

Confirmed Low Testosterone on Two Separate Draws

A single low reading is insufficient. The Endocrine Society and the American Urological Association both recommend confirming low testosterone on two separate morning fasting draws before initiating treatment. Testosterone is subject to natural circadian variation, acute illness effects, and lab-to-lab variability. Two concordant low readings establish a true deficiency pattern.

Symptoms Consistent With Hypogonadism

Labs alone are not enough. A man with a total testosterone of 250 ng/dL and no symptoms requires a different conversation than a man at 250 ng/dL who has fatigue, low libido, difficulty maintaining muscle, and depression. The Endocrine Society’s clinical guidelines recommend initiating TRT only when both biochemical deficiency and consistent symptomatology are present.

Alternative Causes Excluded

Before attributing symptoms to low testosterone, a thorough evaluation must rule out thyroid dysfunction, obstructive sleep apnea, type 2 diabetes, vitamin D deficiency, iron deficiency anemia, depression, and medication effects. Many of these conditions produce overlapping symptoms and are far more common than hypogonadism. Treating the wrong cause wastes time and delays the right intervention.

Who Does Not Benefit From TRT

This is the part of the conversation many clinics skip. It should not be skipped.

Men With Normal Testosterone Levels

If your testosterone is in the normal physiologic range — even the lower end of normal — TRT is unlikely to produce meaningful clinical benefit. The documented benefits of TRT apply to men moving out of the deficient range. Men with low-normal testosterone and bothersome symptoms should first be evaluated thoroughly for the many other conditions that cause those symptoms.

Men Actively Trying to Conceive

TRT suppresses the hypothalamic-pituitary-gonadal axis via negative feedback, dramatically reducing LH and FSH — the hormones that stimulate sperm production. Azoospermia (absent sperm) or severe oligospermia is a predictable consequence of TRT in most men. For men with fertility goals, alternatives including clomiphene citrate, enclomiphene, or HCG therapy can stimulate endogenous testosterone production without suppressing fertility.

Men With Certain Cardiovascular or Hematologic Risk Factors

TRT raises hematocrit. For most patients, this effect is manageable with monitoring, but men with polycythemia, untreated severe sleep apnea, or recent thrombotic events require individualized risk-benefit evaluation before therapy is appropriate. These are not automatic disqualifiers — but they are reasons a thorough physician evaluation matters more, not less.

Men With Active Prostate Cancer

TRT is contraindicated in men with known or suspected prostate cancer. PSA measurement and clinical prostate assessment are standard components of pre-treatment evaluation.

How We Evaluate Candidacy: The Diagnostic Process

At Lite Medical PLLC, TRT evaluation goes well beyond a testosterone level. Our initial panel typically includes:

Total testosterone — morning fasting draw, repeated if abnormal
Free testosterone — the biologically active fraction not bound to SHBG
Sex hormone-binding globulin (SHBG) — elevated SHBG can suppress free T even when total T appears adequate
LH and FSH — to distinguish primary from secondary hypogonadism
Estradiol — aromatase activity, symptom correlation, and treatment monitoring
Prolactin — elevated levels suggest pituitary pathology and require imaging evaluation
Complete blood count (CBC) — baseline hematocrit and hemoglobin
Comprehensive metabolic panel — liver and kidney function, glucose, electrolytes
Thyroid panel (TSH, free T4) — thyroid dysfunction is a common mimic
PSA — prostate baseline, required before initiating TRT
Lipid panel and HbA1c — metabolic context and cardiovascular risk assessment
Vitamin D (25-OH) — deficiency is extremely common in Minnesota and contributes to fatigue, mood, and testosterone metabolism

This panel is not exhaustive for every patient, and additional testing is ordered based on clinical history. The point is that TRT candidacy is a clinical judgment requiring comprehensive data — not a marketing funnel endpoint.

What the Research Shows

The evidence base for TRT in confirmed hypogonadism is substantial and has matured significantly over the past decade.

The Testosterone Trials (TTrials), a coordinated series of seven randomized trials published in 2016 in the New England Journal of Medicine and associated journals, remains the most comprehensive dataset available. In men aged 65 and older with low testosterone, TRT improved sexual function, physical function, mood, bone density, and anemia to varying degrees across the trials. These were not fringe findings — they were robust, replicated outcomes in well-characterized hypogonadal patients.

The 2023 TRAVERSE trial added important cardiovascular context, finding no increased risk of major adverse cardiovascular events in a larger middle-aged hypogonadal population. The American College of Cardiology and major endocrine societies have incorporated these findings into updated guidance.

Meta-analyses published in the Journal of Sexual Medicine and the European Journal of Endocrinology consistently show improvements in libido, erectile function, body composition, and metabolic markers in men treated with TRT for confirmed deficiency. The signal is clear and consistent — in the right patient.

Guideline bodies including the Endocrine Society, the American Urological Association, and the European Association of Urology all endorse TRT for symptomatic hypogonadism with confirmed biochemical deficiency. Their guidance is largely aligned on the importance of pre-treatment evaluation, realistic outcome expectations, and ongoing monitoring.

Myths vs. Facts

Myth: TRT causes prostate cancer.
Fact: Decades of research have not established a causal link between TRT and prostate cancer development. The Endocrine Society’s guidelines acknowledge that while TRT is contraindicated in men with known or suspected prostate cancer, there is no credible evidence that TRT causes prostate cancer in men without the disease. PSA monitoring remains standard during treatment.

Myth: If your testosterone is “low-normal,” TRT will still help you feel better.
Fact: The clinical benefits of TRT are documented in men with confirmed deficiency, not in men with low-normal levels. For men whose symptoms persist despite adequate testosterone, the evaluation should focus on thyroid, sleep, metabolic health, and mental health — not hormone supplementation.

Myth: TRT makes you aggressive or emotionally unstable.
Fact: TRT at physiologic replacement doses — designed to restore testosterone to normal range, not supraphysiologic levels — does not cause aggression. In hypogonadal men, TRT frequently improves mood, reduces irritability, and decreases symptoms of depression. Aggressive behavior is associated with supraphysiologic levels seen in anabolic steroid misuse, not therapeutic replacement.

Myth: You’ll be on TRT forever once you start.
Fact: While many men choose to continue long-term after experiencing benefit, TRT can be discontinued. A structured tapering approach with HPTA stimulation (using medications like clomiphene or HCG) can support recovery of endogenous production in some men, particularly those who have been on TRT for shorter durations.

Myth: TRT is only for older men.
Fact: Hypogonadism occurs across all adult age groups. Secondary hypogonadism — related to hypothalamic-pituitary dysfunction, obesity, stress, or opioid use — is increasingly identified in men in their 30s and 40s. Age alone is neither an indication for nor a barrier to treatment.

Myth: A single testosterone test is all you need to know if TRT is right for you.
Fact: Responsible evaluation requires a minimum of two fasting morning draws, plus a comprehensive panel including free testosterone, SHBG, LH, FSH, and multiple other markers. A single result in isolation — particularly in the afternoon or during illness — is diagnostically insufficient.

Lite Medical’s Clinical Approach

At Lite Medical PLLC, we approach testosterone evaluation the way a good physician should: with curiosity, comprehensiveness, and honesty.

Our evaluations begin with a thorough clinical history — symptoms, timeline, health background, current medications, lifestyle factors, and goals. This conversation takes place before any labs are ordered, because context determines what we’re actually looking for.

We order a comprehensive hormone and metabolic panel and review results in clinical context rather than simply flagging values below the population reference range. The reference range is not an optimal range. A man with a total testosterone of 310 ng/dL — technically “normal” — may have a free testosterone that is functionally deficient given his SHBG level. That distinction matters, and catching it requires a physician who knows how to read the full picture.

When TRT is appropriate, we work with each patient to select the delivery method that best fits their life — injection frequency preferences, skin sensitivity, lifestyle logistics. We monitor closely: hematocrit, PSA, estradiol, lipids, and testosterone levels at structured intervals.

When TRT is not the right answer, we say so — and we do the work to find out what is. That may mean thyroid optimization, vitamin D repletion, metabolic intervention, referral for sleep evaluation, or a different hormonal conversation entirely.

Our Premier Discovery Intake at litemedicalclinic.com/premier-discovery-intake/ is where this evaluation begins. It is designed to be thorough enough to give you real answers — not a sales consultation dressed up as medicine. Learn more about our Testosterone Replacement Therapy program or Hormone Replacement Therapy for Men.

Hormone Health in Saint Paul: What We See at Lite Medical

Saint Paul draws a diverse, civically engaged professional population — state government workers, educators, healthcare professionals, and a substantial creative and arts community. What we consistently see in patients from Saint Paul is a high level of health literacy combined with a healthy skepticism toward over-medicalization. These are patients who want the evidence, want the reasoning, and want a physician who will be direct with them. That is exactly the conversation we are built for at our Twin Cities clinic. When testosterone questions arise here, they tend to be thoughtful ones — and they deserve equally thoughtful answers.

Frequently Asked Questions

What testosterone level qualifies someone for TRT?

There is no single cutoff that universally defines TRT candidacy. The Endocrine Society uses a threshold of total testosterone below 300 ng/dL as a general guide for biochemical deficiency, but this must be confirmed on two separate morning fasting draws. Free testosterone and SHBG add important clinical context. A man with a borderline total testosterone may have functionally low free testosterone depending on his SHBG level. Candidacy is always a clinical judgment that incorporates labs, symptoms, health history, and alternative diagnoses — not a single number.

Can TRT improve my energy if my testosterone is low-normal?

Likely not in a meaningful or sustained way. The documented benefits of TRT apply to men with confirmed deficiency — not men whose levels fall in the lower portion of the normal range. If fatigue is your primary complaint and your testosterone is low-normal, the evaluation should focus on thyroid function, sleep quality, insulin resistance, vitamin D deficiency, anemia, and mood — conditions that are far more common and more likely to explain the symptom at that hormone level. Treating the wrong cause does not make symptoms better; it delays finding what actually will.

Will TRT affect my ability to have children?

Yes. TRT suppresses the hypothalamic-pituitary-gonadal axis through negative feedback, which reduces LH and FSH production and dramatically decreases sperm production. Most men on TRT develop azoospermia or severe oligospermia. This effect is often — but not always — reversible after discontinuation. Men who have not completed their families should discuss fertility-preserving alternatives such as clomiphene citrate, enclomiphene, or human chorionic gonadotropin (HCG) before initiating TRT. These options can stimulate endogenous testosterone production without the same suppressive effect on spermatogenesis.

What is the difference between total testosterone and free testosterone?

Total testosterone measures all testosterone in the bloodstream, including testosterone bound to proteins — primarily sex hormone-binding globulin (SHBG) and albumin. Free testosterone is the small fraction not bound to any protein and available for immediate biological activity. Elevated SHBG — common with aging, hyperthyroidism, certain medications, and low BMI — can bind a disproportionate share of total testosterone, leaving free testosterone functionally low even when total testosterone appears adequate. This is why evaluating SHBG and free testosterone alongside total testosterone gives a far more accurate clinical picture.

How long does it take to feel the effects of TRT?

Response timing varies by symptom domain. Libido and mood often improve within the first four to six weeks. Energy and motivation improvements may follow over one to three months. Changes in body composition — reduced fat mass, increased lean mass — typically require three to six months of consistent therapy, alongside appropriate nutrition and resistance exercise. Bone density improvements take twelve to twenty-four months to appear on imaging. Individual response variability is substantial, and realistic expectations — set at the outset of therapy — matter for both patient satisfaction and clinical decision-making.

Does TRT increase the risk of heart attack or stroke?

The cardiovascular risk profile of TRT has been significantly refined by recent evidence. The TRAVERSE trial, published in the New England Journal of Medicine in 2023, was a large randomized controlled trial specifically powered to assess cardiovascular outcomes. It found no increase in major adverse cardiovascular events (heart attack, stroke, or cardiovascular death) compared to placebo in middle-aged and older men with hypogonadism. However, TRT was associated with a modestly higher rate of atrial fibrillation and pulmonary embolism, which warrants individualized risk-benefit discussion in patients with relevant histories. Overall, for appropriately selected patients without contraindications, TRT is not considered high cardiovascular risk by current guidelines.

What monitoring is required during TRT?

Responsible TRT management includes structured follow-up monitoring. At Lite Medical PLLC, we typically reassess testosterone levels (total and free), hematocrit, estradiol, and PSA at three to six months after initiation and at regular intervals thereafter. Hematocrit elevation is the most common laboratory concern during therapy; levels above 54% require dose adjustment or temporary discontinuation. PSA monitoring is standard for prostate cancer surveillance. Lipid panels and metabolic markers are reviewed on an individualized basis based on baseline risk profile and treatment duration.

Can I start TRT and stop it later if I change my mind?

Yes, TRT can be discontinued. However, stopping TRT after a period of treatment typically results in a transient reduction in testosterone below pre-treatment levels as the hypothalamic-pituitary-gonadal axis recovers. This recovery period — lasting weeks to months — may involve worsening fatigue and reduced libido. A structured discontinuation approach using HPTA-stimulating agents such as clomiphene or HCG can support and accelerate recovery in some patients. The likelihood of returning to pre-treatment endogenous testosterone levels depends on the duration of therapy, age, and underlying baseline function.

Is TRT available for men in their 30s?

Absolutely. Hypogonadism is not limited to older men. Secondary hypogonadism — driven by hypothalamic-pituitary dysfunction rather than testicular failure — is increasingly identified in younger men and is associated with obesity, opioid use, certain medications, sleep disorders, and chronic stress. When a man in his 30s has confirmed biochemical deficiency and consistent symptoms, and alternative causes have been appropriately excluded, TRT is a clinically valid option. Age is not a disqualifying or automatically qualifying factor — the evaluation and clinical picture are what matter.

What delivery method is best — injections, gels, or pellets?

There is no universally best delivery method. Each has advantages and limitations. Intramuscular and subcutaneous injections (testosterone cypionate or enanthate) produce predictable pharmacokinetics, allow dose titration flexibility, and are cost-effective. The limitation is injection frequency — typically weekly or biweekly. Topical gels and creams provide steady daily delivery with less hormonal cycling but carry a risk of transference to partners or children via skin contact. Subcutaneous pellets offer a low-maintenance every-three-to-five-month option but lack dose adjustability once placed. The best method is the one the patient will consistently adhere to and that fits their clinical and lifestyle profile.

How does Lite Medical differ from other men’s health clinics?

The primary difference is the depth of evaluation. Many clinics offer a streamlined intake that prioritizes treatment speed. Lite Medical PLLC’s approach prioritizes diagnostic accuracy first — comprehensive labs, detailed clinical history, honest discussion of whether TRT is actually the right answer. Some men who come to us expecting a TRT prescription leave with a thyroid optimization plan or a referral for sleep evaluation because that is what their data indicates. That commitment to getting the answer right, rather than simply filling a prescription, is what physician-led care means in practice.

Does TRT help with erectile dysfunction?

TRT improves libido and sexual interest reliably in hypogonadal men. Its effect on erectile function is more variable. Testosterone plays a role in the nitric oxide pathway involved in erections, and hypogonadal men often experience improvement in erectile quality with TRT. However, erectile dysfunction in men with adequate testosterone frequently has vascular, neurogenic, or psychological contributors that TRT does not address. In those cases, combining TRT with appropriate ED treatment may be appropriate, or the evaluation may reveal that TRT is not the limiting factor. A thorough clinical assessment should guide the decision rather than a blanket assumption that low testosterone explains all sexual dysfunction.

Related Lite Medical Services

Low Testosterone in Minneapolis: Signs, Labs, and When TRT Actually Helps
TRT in Eden Prairie: What Lite Medical’s Hormone Optimization Program Includes
TRT in Bloomington: A Physician’s Guide to Starting, Monitoring, and Adjusting Therapy
Avoiding Ozempic Face: How We Protect Muscle Mass During GLP-1 Weight Loss
Low Testosterone in Woodbury: How Lite Medical Tests for Hypogonadism Beyond Routine Screening

References

U.S. Food and Drug Administration (FDA) — fda.gov
National Institutes of Health (NIH) — nih.gov
Endocrine Society Clinical Practice Guidelines — endocrine.org
American Urological Association Guidelines — auanet.org
American College of Cardiology / AHA — acc.org
PubMed / National Library of Medicine — pubmed.ncbi.nlm.nih.gov

Medical Disclaimer

This article is intended for educational purposes only and should not be interpreted as personalized medical advice. Medical decisions should be made in consultation with a licensed healthcare professional who is familiar with your medical history. Treatment plans are individualized, and results vary. Lite Medical PLLC does not provide emergency medical care.

Medication & Regulatory Disclosure

Testosterone replacement therapy requires a valid prescription from a licensed physician. FDA-approved testosterone formulations are available in multiple delivery forms. Some formulations dispensed by compounding pharmacies are not FDA-approved as finished drug products. Lite Medical PLLC prescribes testosterone therapies based on individualized patient evaluation and in accordance with applicable federal and state regulations. Results vary. All prescribing decisions are made by a licensed physician following a comprehensive clinical evaluation.